By studying naevi, this CRE will create tangible outcomes within 5 main aims:
Generate new knowledge on the naevus life cycle, and correlate phenotypic characteristics with germline genotypic findings to identify genetic markers that can ultimately contribute to personalised medicine via risk stratified naevi prevention and surveillance programs.
Build a reference annotated naevus database as a valuable international resource in collaboration with the International Societies for Digital Imaging of the Skin (led by Prof Allan Halpern) and Dermoscopy (led by Prof Hofmann-Wellenhof).
Generate new evidence for risk-adjusted early detection of melanoma and translate research outcomes into improved professional and patient education materials, and melanoma prevention, early detection and clinical practice guidelines.
Facilitate collaboration, and develop the health and medical research workforce in clinical dermatology, teledermatology, epidemiology, genetics, molecular biology, behavioural science, nanotechnology and bioinformatics.
Inspire young clinicians and scientists to use the latest technological advances in skin cancer diagnostics and care with a focus on policy development and commercial enterprises.